The development and validation of a clinical measurement tool for fear of recurrence and progression in cardiac patients

开发和验证用于评估心脏病患者复发和病情进展恐惧的临床测量工具

阅读:1

Abstract

One in two cardiac patients fear having another heart event or their cardiac condition worsening. Assessment of fear of recurrence and progression (FoRP) is critical to effective clinical care and chronic disease management. The current study aimed to develop and validate a measure of cardiac-FoRP - The Fear of Cardiac Recurrence and Progression Inventory (FCRPI). Items were generated by reviewing relevant literature and were refined in collaboration with key informants. The item pool (44 items) was administered to 241 adults (mean age = 64.52; 50% female) with a history of an acute coronary event, cardiac surgery, or chronic cardiac condition. Exploratory factor analysis identified the underlying factor structure and Rasch analysis assessed fit and reduced the item set. The final FCRPI comprised 29 items across five fear subscales relating to: deteriorating health, requiring further treatment, disengagement and loss of agency, impacts on intimacy, and impacts on work and finance, and two fear response subscales: avoidance and hyperawareness. The FCRPI demonstrated excellent internal consistency, and criterion and discriminant validity, and a clinically significant cut-off score of 39 was identified. The FCRPI offers both research and clinical utility by providing a validated tool to assess cardiac-specific FoRP and guide tailored interventions and patient-centred care. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1038/s41598-026-40353-5.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。